Duluth (NASDAQ:DLTH – Get Free Report)‘s stock had its “sell (d-)” rating reaffirmed by equities researchers at Weiss Ratings in a report issued on Tuesday,Weiss Ratings reports.
Several other research analysts have also issued reports on the company. Baird R W raised Duluth from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 5th. Singular Research upgraded Duluth to a “strong-buy” rating in a research note on Monday. Finally, Robert W. Baird upgraded Duluth from a “neutral” rating to an “outperform” rating and boosted their price target for the company from $2.00 to $7.00 in a research note on Friday, September 5th. Two research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of $7.00.
Read Our Latest Report on DLTH
Duluth Trading Up 0.3%
Duluth (NASDAQ:DLTH – Get Free Report) last announced its earnings results on Thursday, September 4th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.08. Duluth had a negative return on equity of 14.31% and a negative net margin of 7.99%.The company had revenue of $131.72 million for the quarter, compared to analyst estimates of $124.03 million. Duluth has set its FY 2025 guidance at EPS. On average, research analysts predict that Duluth will post -0.56 earnings per share for the current fiscal year.
Insider Activity at Duluth
In related news, CFO Heena Agrawal bought 10,000 shares of the business’s stock in a transaction dated Friday, September 26th. The stock was acquired at an average price of $3.50 per share, with a total value of $35,000.00. Following the completion of the purchase, the chief financial officer directly owned 248,093 shares of the company’s stock, valued at approximately $868,325.50. This trade represents a 4.20% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. 42.94% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Duluth
Hedge funds and other institutional investors have recently made changes to their positions in the company. Goldman Sachs Group Inc. lifted its position in shares of Duluth by 50.8% in the first quarter. Goldman Sachs Group Inc. now owns 87,615 shares of the company’s stock valued at $152,000 after acquiring an additional 29,521 shares in the last quarter. Yarger Wealth Strategies LLC lifted its holdings in Duluth by 124.5% in the 2nd quarter. Yarger Wealth Strategies LLC now owns 32,419 shares of the company’s stock valued at $68,000 after purchasing an additional 17,978 shares in the last quarter. Empowered Funds LLC lifted its holdings in Duluth by 9.3% in the 1st quarter. Empowered Funds LLC now owns 101,447 shares of the company’s stock valued at $177,000 after purchasing an additional 8,597 shares in the last quarter. Finally, International Assets Investment Management LLC purchased a new position in Duluth in the 2nd quarter valued at $50,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.
Duluth Company Profile
Duluth Holdings Inc sells casual wear, workwear, and accessories for men and women under the Duluth Trading brand in the United States. It provides shirts, pants, underwear, tanks, outerwear, footwear, accessories, and hard goods. The company offers its products under various trademarks, trade names, and service marks, including Alaskan Hardgear, Armachillo, Ballroom, Bucket Master, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No-Yank, No Polo Shirt, Wild Boar Mocs, and Buck Naked.
See Also
- Five stocks we like better than Duluth
- Dividend Capture Strategy: What You Need to Know
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Duluth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Duluth and related companies with MarketBeat.com's FREE daily email newsletter.